Unlock instant, AI-driven research and patent intelligence for your innovation.

Antibody-dna conjugates and HPV detection and treatment

A conjugate and DNA sequence technology, applied in the field of antibody DNA conjugates and HPV detection and treatment, can solve the problems of low cost and scalability

Pending Publication Date: 2021-09-17
PSOMAGEN INC
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In contrast, the detection and characterization of other non-DNA targets is still underdeveloped and mainly done by highly specialized laboratories, limited by their cost and low scalability

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibody-dna conjugates and HPV detection and treatment
  • Antibody-dna conjugates and HPV detection and treatment
  • Antibody-dna conjugates and HPV detection and treatment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0300] Embodiments (eg, of one or more methods, one or more systems, such as compositions, etc.) may additionally or alternatively include:

[0301] In some embodiments, the present disclosure provides a method of treating or preventing HPV 11 infection, comprising administering to a patient in need thereof a polypeptide comprising: (a) a sequence (and / or a sequence of sequences) comprising at least one of the following Suitable portions, such as epitopes of at least 7, optionally at least 8 contiguous amino acids): PVFITGSDF, LSTPQRLVT, FVVAVLGLL, TPFSPVTPA, LPVVIAFAV, LVAAENDTF, PSDSTVYVP, GAPEVVPPT, SDSTVYVPP, QGNTVEVKF, LVLTLLLYL, RVGLYSRAL, LILPVVIAF, TSSESTTPA, DSNVRLVVE、VLIILISDF、KPRARRRKR、VQIAAATTT、RRLFETREL、LTDAKVALL、MADDSALYE、EVVPVQIAA、NAVYELSDA、SSESTTPAI、QIAAATTTT、KIQSGVRAL、TVARTLGTL、STSATSIDQ、TSSLTITTS、ETNEDILKV、TVQSTTSSL、RALQQVQVT、LKDIVLDLQ、PVQIAAATT、YSIKKVNKT、PRARRRKRA、ASTSATSID、RKHRALTLI、ADDSALYEK、 KCKDIRSTL, STTSSLTIT, RKTACRRRL, VVIAFAVCI, AIAKRLDAC and / or MEV...

Embodiment 1

[0421] Example 1: Identification of epitopes from the proteome of HPV

[0422] As an example of the methods described herein, epitopes were identified from the proteomes of HPV types 6 (777 sequences), 11 (719 sequences), 16 (1278 sequences) and 18 (740 sequences) .

[0423] From those sequences, 3514 epitopes from the T cell prediction server were predicted. After discarding repetitive sequences, only 823 "de novo" epitopes were generated, which were aligned against proteins belonging to 148 species belonging to Lactobacillus and Fusobacterium nucleatum. Thus, 155 "common epitopes" between HPV and Lactobacillus proteins and 1 common epitope between HPV and F. nucleatum proteins were obtained. Those epitopes that did not meet the criteria described herein were discarded.

[0424] Of the 156 "de novo" epitopes, 5 of them also belong to bacteria known to be associated with HPV infection. They are: RAAKRRLFE epitope from HPV 16 and L. campylobacter, GGQTVQVYF and KGGQTVQVY ep...

Embodiment 2

[0496] Example 2: Identification of epitopes (777 segments) from the proteome of HPV6

[0497] From those sequences, a preliminary set of T-cell epitopes was obtained, which was subjected to the following multiple filtration processes: discarding repetitive sequences, matching 148 (and / or an appropriate number) of F. nucleatum and Lactobacillus The protein alignment of those species. Through this process, a set of common epitopes between HPV and Lactobacillus proteins was obtained. For example, an epitope (KNALTTAEI) shared between HPV type 6 and proteins from Fusobacterium nucleatum, Lactobacillus congeners, Lactobacillus fucoides, and Lactobacillus stevii was determined. Those epitopes that did not meet the criteria were discarded.

[0498] The list of epitopes may additionally or alternatively include those shown in the following table (Table 7). Additionally, the binding energies from the docking simulations, expressed in kcal / mol, are also listed. Binding energy can b...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present disclosure relates to a method of detecting a molecule using an antibody-DNA conjugate, and pharmaceutical compositions comprising new polypeptides and use thereof.

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS [0002] This application claims U.S. Provisional Patent Application No. 62 / 797,165, filed January 25, 2019, entitled "Beyond Nucleic Acid Detection: DNA-LISA," and entitled "Epitope-Based Approach For U.S. Provisional Patent Application No. 62 / 797,167 to A HPV6 Treatment And Detection Method, System, And Therapeutic Compositions"; filed Jan. 25, 2019, titled "Epitope-Based Approach For A HPV11 Treatment And Detection Method, System, And Therapeutic U.S. Provisional Patent Application No. 62 / 797,171, "Compositions"; U.S. Provisional Patent No. 62 / 797,173, filed January 25, 2019, entitled "Epitope-Based Approach For A HPV16 Treatment And Detection Method, System, And Therapeutic Compositions" Application; U.S. Provisional Patent Application No. 62 / 797,175, filed Jan. 25, 2019, titled "Epitope-Based Approach For A HPV18 Treatment AndDetection Method, System, And Therapeutic Compositions," filed Jan. 31, 2019 is the benefit of US Prov...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/70C12Q1/686C07K14/335C07K7/06A61K38/08A61P31/20
CPCC12Q1/708C12Q1/70A61K38/00C07K14/005C07K14/335G01N33/56983G01N2333/025C12Q2531/113C12Q2563/131C12Q2565/50C07K7/06A61P31/20
Inventor 扎卡里·阿普特杰西卡·里克曼丹尼尔·阿莫纳西德贾尼拉·埃斯皮诺萨马里奥·萨维德拉
Owner PSOMAGEN INC